Paul Hudson

Mr. Hudson has been a member of our board since October 2026, bringing more than three decades of senior executive leadership across some of the world’s most prominent biopharmaceutical companies. He most recently served as Chief Executive Officer of Sanofi S.A. from 2019 to 2026, where he led a sweeping transformation of the organization. Prior to Sanofi, Mr. Hudson served as Chief Executive Officer of Novartis Pharmaceuticals from 2016 to 2019 and as a member of the Novartis Executive Committee. His career in healthcare has spanned the globe, with roles in the U.S., Japan, and Europe. Prior to Novartis, he held a series of senior operational and commercial leadership positions at AstraZeneca, including President of AstraZeneca United States and Executive Vice President, North America. Earlier in his career, Mr. Hudson held sales and marketing positions at Schering-Plough, GlaxoSmithKline UK, and Sanofi-Synthélabo UK. Mr. Hudson holds a degree in economics from Manchester Metropolitan University and a diploma in marketing from the Chartered Institute of Marketing.